M.S. degree with honors
,
chemistry

Dr. Gordon Chiu is Focus Graphite's Chief Scientist and is Vice President and co-founder of Grafoid Inc.
Described as an "execution-driven businessman," Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries.
A lecturer and corporate advisor, Dr. Chiu is engaged in the discovery and research of graphene on behalf of Grafoid and provides advice on project selection with a view to increasing overall shareholder value.

Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia.He holds a B.S. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute; graduated with an M.S. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program at the Mount Sinai School of Medicine.He jointly combined his cumulative training with an ND degree in naturopathic medicine from the University of Bridgeport.

Described as an "execution-driven businessman," Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries.
He is co-founder at Grafoid Inc., where he is currently President and Chief Technology Officer.Dr. Chiu is engaged in the discovery and research of graphene on behalf of Grafoid and its subsidiaries, as well as the development of graphene applications with Grafoid's joint venture application development partners.He is also Chief Scientist at Focus Graphite Inc.Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia.

Dr. Chiu holds a B.Sc. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute, graduated with a M.Sc. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program (MSTP) at the Mount Sinai School of Medicine.Dr. Chiu jointly combined his cumulative training with a Doctor of Naturopathic Medicine (ND) degree from the University of Bridgeport.

Described as an "execution-driven businessman," Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries.
As President, Chief Technology Officer and co-founder of Grafoid Inc., Dr. Chiu is engaged in the discovery and research of graphene on behalf of Grafoid, as well as the development of graphene applications with Grafoid's joint venture application development partners.He is also Focus Graphite Inc.'s Chief Scientist.Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia.Dr. Chiu holds a B.Sc. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute, graduated with a M.Sc. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program (MSTP) at the Mount Sinai School of Medicine.Dr. Chiu jointly combined his cumulative training with a Doctor of Naturopathic Medicine (ND) degree from the University of Bridgeport.

Dr. Gordon Chiu is Vice President and a co-founder of Grafoid Inc.
Described as an "execution-driven businessman," Dr. Chiu has combined domestic and international experience in the biomedical, chemical, cosmetic, medical, and technology industries.
A lecturer and corporate advisor, Dr. Chiu is engaged in the discovery and research of graphene, graphene derivatives and the development of MesoGraf™-based industrial applications.

Dr. Chiu is a former research scientist at Pfizer Inc. and Merck & Co., Inc. and has healthcare and marketing experience with strong links to Wall Street and Asia.He holds a B.S. degree summa cum laude in chemistry from Rensselaer Polytechnic Institute; graduated with an M.S. degree in chemistry from Seton Hall University with honors, and is globally distinguished by his acceptance as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program at the Mount Sinai School of Medicine.He jointly combined his cumulative training with an ND degree in naturopathic medicine from the University of Bridgeport.

Dr. Chiu is lead advisor to Calevia Inc. and will co-manage the project.He is Co-Founder and Vice-President of Grafoid Inc., a privately held Canadian corporation investing in graphene applications and economically scalable production processes for MesoGraf™ - the global standard for graphene - and MesoGraf™Xide, its trademark graphene oxide produced from raw, unprocessed graphite ore.

Dr. Chiu is also the lead scientist at Focus Graphite, a TSX Venture-listed graphite mining and graphene development company.